Pheochromocytoma Diagnosis and Treatment Market, Global Outlook and Forecast 2022-2028

February 2022 | 64 pages | ID: PAB977490C49EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Pheochromocytoma Diagnosis and Treatment in Global, including the following market information:

Global Pheochromocytoma Diagnosis and Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Pheochromocytoma Diagnosis and Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

by Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pheochromocytoma Diagnosis and Treatment include Exelixis, Inc., MediaPharma s.r.l., Pfizer Inc., Progenics Pharmaceuticals, Inc. and Bausch Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pheochromocytoma Diagnosis and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pheochromocytoma Diagnosis and Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pheochromocytoma Diagnosis and Treatment Market Segment Percentages, by Type, 2021 (%)

• by Diagnosis
• Laboratory Tests
• Imaging Tests
• Genetic Testing
• by Treatment
• Drugs
• Surgery

Global Pheochromocytoma Diagnosis and Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pheochromocytoma Diagnosis and Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics

Global Pheochromocytoma Diagnosis and Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pheochromocytoma Diagnosis and Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pheochromocytoma Diagnosis and Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Pheochromocytoma Diagnosis and Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Exelixis, Inc.
• MediaPharma s.r.l.
• Pfizer Inc.
• Progenics Pharmaceuticals, Inc.
• Bausch Health

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pheochromocytoma Diagnosis and Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pheochromocytoma Diagnosis and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PHEOCHROMOCYTOMA DIAGNOSIS AND TREATMENT OVERALL MARKET SIZE

2.1 Global Pheochromocytoma Diagnosis and Treatment Market Size: 2021 VS 2028
2.2 Global Pheochromocytoma Diagnosis and Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pheochromocytoma Diagnosis and Treatment Players in Global Market
3.2 Top Global Pheochromocytoma Diagnosis and Treatment Companies Ranked by Revenue
3.3 Global Pheochromocytoma Diagnosis and Treatment Revenue by Companies
3.4 Top 3 and Top 5 Pheochromocytoma Diagnosis and Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pheochromocytoma Diagnosis and Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pheochromocytoma Diagnosis and Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Pheochromocytoma Diagnosis and Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pheochromocytoma Diagnosis and Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Pheochromocytoma Diagnosis and Treatment Market Size Markets, 2021 & 2028
  4.1.2 Laboratory Tests
  4.1.3 Imaging Tests
  4.1.4 Genetic Testing
4.2 By Type - Global Pheochromocytoma Diagnosis and Treatment Revenue & Forecasts
  4.2.1 By Type - Global Pheochromocytoma Diagnosis and Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Pheochromocytoma Diagnosis and Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Pheochromocytoma Diagnosis and Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pheochromocytoma Diagnosis and Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinics
5.2 By Application - Global Pheochromocytoma Diagnosis and Treatment Revenue & Forecasts
  5.2.1 By Application - Global Pheochromocytoma Diagnosis and Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Pheochromocytoma Diagnosis and Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Pheochromocytoma Diagnosis and Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pheochromocytoma Diagnosis and Treatment Market Size, 2021 & 2028
6.2 By Region - Global Pheochromocytoma Diagnosis and Treatment Revenue & Forecasts
  6.2.1 By Region - Global Pheochromocytoma Diagnosis and Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Pheochromocytoma Diagnosis and Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Pheochromocytoma Diagnosis and Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Pheochromocytoma Diagnosis and Treatment Revenue, 2017-2028
  6.3.2 US Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.3.3 Canada Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.3.4 Mexico Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Pheochromocytoma Diagnosis and Treatment Revenue, 2017-2028
  6.4.2 Germany Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.4.3 France Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.4.4 U.K. Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.4.5 Italy Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.4.6 Russia Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.4.8 Benelux Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Pheochromocytoma Diagnosis and Treatment Revenue, 2017-2028
  6.5.2 China Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.5.3 Japan Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.5.4 South Korea Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.5.6 India Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Pheochromocytoma Diagnosis and Treatment Revenue, 2017-2028
  6.6.2 Brazil Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.6.3 Argentina Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pheochromocytoma Diagnosis and Treatment Revenue, 2017-2028
  6.7.2 Turkey Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.7.3 Israel Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028
  6.7.5 UAE Pheochromocytoma Diagnosis and Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Exelixis, Inc.
  7.1.1 Exelixis, Inc. Corporate Summary
  7.1.2 Exelixis, Inc. Business Overview
  7.1.3 Exelixis, Inc. Pheochromocytoma Diagnosis and Treatment Major Product Offerings
  7.1.4 Exelixis, Inc. Pheochromocytoma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.1.5 Exelixis, Inc. Key News
7.2 MediaPharma s.r.l.
  7.2.1 MediaPharma s.r.l. Corporate Summary
  7.2.2 MediaPharma s.r.l. Business Overview
  7.2.3 MediaPharma s.r.l. Pheochromocytoma Diagnosis and Treatment Major Product Offerings
  7.2.4 MediaPharma s.r.l. Pheochromocytoma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.2.5 MediaPharma s.r.l. Key News
7.3 Pfizer Inc.
  7.3.1 Pfizer Inc. Corporate Summary
  7.3.2 Pfizer Inc. Business Overview
  7.3.3 Pfizer Inc. Pheochromocytoma Diagnosis and Treatment Major Product Offerings
  7.3.4 Pfizer Inc. Pheochromocytoma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Inc. Key News
7.4 Progenics Pharmaceuticals, Inc.
  7.4.1 Progenics Pharmaceuticals, Inc. Corporate Summary
  7.4.2 Progenics Pharmaceuticals, Inc. Business Overview
  7.4.3 Progenics Pharmaceuticals, Inc. Pheochromocytoma Diagnosis and Treatment Major Product Offerings
  7.4.4 Progenics Pharmaceuticals, Inc. Pheochromocytoma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.4.5 Progenics Pharmaceuticals, Inc. Key News
7.5 Bausch Health
  7.5.1 Bausch Health Corporate Summary
  7.5.2 Bausch Health Business Overview
  7.5.3 Bausch Health Pheochromocytoma Diagnosis and Treatment Major Product Offerings
  7.5.4 Bausch Health Pheochromocytoma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.5.5 Bausch Health Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pheochromocytoma Diagnosis and Treatment Market Opportunities & Trends in Global Market
Table 2. Pheochromocytoma Diagnosis and Treatment Market Drivers in Global Market
Table 3. Pheochromocytoma Diagnosis and Treatment Market Restraints in Global Market
Table 4. Key Players of Pheochromocytoma Diagnosis and Treatment in Global Market
Table 5. Top Pheochromocytoma Diagnosis and Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pheochromocytoma Diagnosis and Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pheochromocytoma Diagnosis and Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pheochromocytoma Diagnosis and Treatment Product Type
Table 9. List of Global Tier 1 Pheochromocytoma Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pheochromocytoma Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pheochromocytoma Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pheochromocytoma Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pheochromocytoma Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pheochromocytoma Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pheochromocytoma Diagnosis and Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pheochromocytoma Diagnosis and Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Exelixis, Inc. Corporate Summary
Table 31. Exelixis, Inc. Pheochromocytoma Diagnosis and Treatment Product Offerings
Table 32. Exelixis, Inc. Pheochromocytoma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 33. MediaPharma s.r.l. Corporate Summary
Table 34. MediaPharma s.r.l. Pheochromocytoma Diagnosis and Treatment Product Offerings
Table 35. MediaPharma s.r.l. Pheochromocytoma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Inc. Corporate Summary
Table 37. Pfizer Inc. Pheochromocytoma Diagnosis and Treatment Product Offerings
Table 38. Pfizer Inc. Pheochromocytoma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Progenics Pharmaceuticals, Inc. Corporate Summary
Table 40. Progenics Pharmaceuticals, Inc. Pheochromocytoma Diagnosis and Treatment Product Offerings
Table 41. Progenics Pharmaceuticals, Inc. Pheochromocytoma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Bausch Health Corporate Summary
Table 43. Bausch Health Pheochromocytoma Diagnosis and Treatment Product Offerings
Table 44. Bausch Health Pheochromocytoma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Pheochromocytoma Diagnosis and Treatment Segment by Type in 2021
Figure 2. Pheochromocytoma Diagnosis and Treatment Segment by Application in 2021
Figure 3. Global Pheochromocytoma Diagnosis and Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pheochromocytoma Diagnosis and Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pheochromocytoma Diagnosis and Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pheochromocytoma Diagnosis and Treatment Revenue in 2021
Figure 8. By Type - Global Pheochromocytoma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pheochromocytoma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pheochromocytoma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pheochromocytoma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 12. US Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pheochromocytoma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pheochromocytoma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 24. China Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pheochromocytoma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pheochromocytoma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pheochromocytoma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Exelixis, Inc. Pheochromocytoma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. MediaPharma s.r.l. Pheochromocytoma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Inc. Pheochromocytoma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Progenics Pharmaceuticals, Inc. Pheochromocytoma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bausch Health Pheochromocytoma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)